Skip to main content
SpringerLink
Log in

REVIEW: Overlap Syndromes of Autoimmune Hepatitis: What Is Known So Far

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The pattern of some autoimmune hepatitis can be difficult to classify, sometimes due to the overlap of these with primary biliary cirrhosis, primary sclerosing cholangitis and chronic viral hepatitis. The etiology of these variant forms remains unclear. The distinction among the overlap syndromes poses different problems both of prognosis and therapeutic approach. Presently, the utility of the scoring system devised and revised by the International Autoimmune Hepatitis Group regarding these cases is under discussion. Histological examination seems to be an important tool, but often the result does not help in defining a correct diagnosis. To date, the overlap syndromes can be classified at an intermediate level between cholestatic forms of autoimmune hepatitis or hepatic forms of cholestatic syndromes, but it cannot be excluded that the syndromes represent independent disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Obermayer-Straub P, Stassburg CP, Manns MP: Autoimmune hepatitis. J Hepatol 32(1):181-197, 2000

    Google Scholar 

  2. Park SZ, Nagorney DM, Czaja AJ: Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci 45:1944-1948, 2000

    Google Scholar 

  3. Johnson PG, McFarlane IG: Meeting report: international autoimmune hepatitis group. Hepatology 18:998-1005, 1993

    Google Scholar 

  4. Alvarez F, Berg PA, Bianchi FP, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:928-937, 1999

    Google Scholar 

  5. Lenzi M, Bellentani S, Saccoccio G, Muratori G, Masutti F, Muratori L, Cassani F, Bianchi FB, Tiribelli C: Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45(3):435-441, 1999

    Google Scholar 

  6. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in Norwegian population. Scand J Gastroenterol 33(1):99-103, 1998

    Google Scholar 

  7. Lee YM, Teo EK, Ng TM, Khor C, Fock KM: Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J Gastroenterol Hepatol 16(12):1384-1389, 2001

    Google Scholar 

  8. Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH: Autoimmune hepatitis: the investigational and clinic challenges. Hepatology 31:1194-1200, 2000

    Google Scholar 

  9. Fagoonee S, Pellicano R, Rizzetto M, Ponzetto A: The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. Panminerva Med 43(4):279-282, 2001

    Google Scholar 

  10. Spinzi G, Pellicano R, Minoli G, Terreni N, Cutufia MA, Fagoonee S, Rizzetto M, Ponzetto A: Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med 43(2):85-87, 2001

    Google Scholar 

  11. Durazzo M, Pellicano R, Premoli A, Berrutti M, Leone N, Ponzetto A, Rizzetto M: Helicobacter pylori seroprevalence in patients with autoimmune hepatitis. Dig Dis Sci 47(2):380-283, 2002

    Google Scholar 

  12. Czaja AJ, Santrach PJ, Moore SB: Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 46(1):140-147, 2001

    Google Scholar 

  13. Heneghan MA, McFarlane IG: Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35(1):7-13, 2002

    Google Scholar 

  14. Van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP: High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 33:543-548, 2000

    Google Scholar 

  15. Ben-Ari Z, Czaja AJ: Autoimmune hepatitis and its variant syndromes. Gut 49:589-594, 2001

    Google Scholar 

  16. Brunner G, Klinge O: A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies(immunocholangitis). Dtsch Med Wochenschr 112(38):1454-1458, 1987

    Google Scholar 

  17. Ben-Ari Z, Dhillon AP, Sherlock S: Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18(1):10-15, 1993.

    Google Scholar 

  18. Michieletti P. Wanless IR, Katz A, Schever PJ, Yeaman SJ, Bassendwe MF, Palmer JM, Haethcote EJ: Anti-mitochondrial antibodies negative primary biliary cirrhosis: a distinct sindrome of autoimmune cholangitis. Gut 35:260-265, 1994

    Google Scholar 

  19. Godman ZD McNally PR, Davis DR, Ishak KG: Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 40:1232-1242, 1995

    Google Scholar 

  20. Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeney SJ, Whittingham S, Mackay IR: Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 28(3):255-258, 1996

    Google Scholar 

  21. Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, Zuin M, Podda M: Comparison of the clinical features and the clinical course of anti-mitochondrial antibodies positive and negative primary biliary cirrhosis. Hepatology 25:1090-1095, 1997

    Google Scholar 

  22. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Khono S, Nakanuma Y, Penner E, Wesierska-Gadek J, Reynoso-Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR: Autoimmune cholangitis and primary biliary cirrhosis—an autoimmune enigma. Liver 19(2):122-128, 1999

    Google Scholar 

  23. Czaja AJ: The variant forms of autoimmune hepatitis. Ann Intern Med 125(7):588-598, 1996

    Google Scholar 

  24. Sherlock S: Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? Mayo Clin Proc 73(2):184-190, 1998

    Google Scholar 

  25. Sanchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA: Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J Clin Gastroenterol 23(3):191-198, 1996

    Google Scholar 

  26. Perdigoto R, Carpenter HA, Czaja AJ: Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 14:325-331, 1992

    Google Scholar 

  27. Wee A, Ludwig J: Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 102:581-587, 1985

    Google Scholar 

  28. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31:1231-1238, 2000

    Google Scholar 

  29. Domoulin J, Leifeld L, Sauerbruch T, Spengler U: Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 53:242-254, 1999

    Google Scholar 

  30. Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD: Does anti-mitochondrial antibodies status affect response to treatment in patients with primary biliary cirrhosis? Outcames of ursodeoxycholic acid therapy and liver transplantation. Hepatology 26:22-26, 1997

    Google Scholar 

  31. Durazzo M, Bresso F, Premoli A, Rabbione L: Variant syndromes in autoimmune hepatic diseases. Min Gastroenterol Dietol 47:27-38, 2001

    Google Scholar 

  32. Gershwin ME: The natural history of primary biliary cirrhosis: of genes and cooperation. J Hepatol 35(3):412-415, 2001

    Google Scholar 

  33. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28(2):296-301, 1998

    Google Scholar 

  34. Geubel AP, Baggenstoss AH, Summerskill WH: Responses to treatment can differentiate crhonic active liver disease with cholangitis features from the primary biliary cirrhosis syndrome. Gastroenterology 71:444-449, 1976

    Google Scholar 

  35. Shouval D, Levij IS, Eliakim M: Chronic active hepatitis with cholestatic features. Am J Gastroenterol 72:542-550, 1979

    Google Scholar 

  36. Kenny RP, Czaja AJ, Ludwig J, Dickson ER: Frequency and significance in antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 31:705-711, 1986

    Google Scholar 

  37. Czaja AJ: Frequency and nature of the variant sindromes of autoimmune liver disease. Hepatology 28:360-365, 1998

    Google Scholar 

  38. Lohse WA, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP: Characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: evidence for it being a hepatitic form of primary biliary cirrhosis in genetically susceptible individuals. Hepatology 29:1078-1084, 1999

    Google Scholar 

  39. Kaplan MM: Primary biliary cirrhosis. N Engl J Med 335:1570-1580, 1996

    Google Scholar 

  40. Krawitt E: Autoimmune hepatits. N Engl J Med 334:897-903, 1996

    Google Scholar 

  41. Goldstein NS, Soman A, Gordon SC: Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, midly active primary biliary cirrhosis and autoimmune hepatitis. Am J Clin Pathol 116(6):846-853, 2001

    Google Scholar 

  42. Vyberg M: The hepatitis-associated bile duct lesion. Liver 13:289-301, 1993

    Google Scholar 

  43. Colombato LA, Alvarez F, Cote J, Huvet PM: Autoimmune cholangiopaty: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 107:1839-1843, 1994

    Google Scholar 

  44. Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ: Primary biliary cirrhosis additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 35(2):409-413, 2002

    Google Scholar 

  45. Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R: Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acid in the mause. Gastroenterology 103:617-621, 1992

    Google Scholar 

  46. Duclos-Vallee JC, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: corticoresistance and effective treatment with cyclosporine A. Dig Dis Sci 40:1069-1073, 1995

    Google Scholar 

  47. Lobo-Yeo A, McSorley C, McFarlane BM, Mieli-Vergani G, Mowat AP, Vergani D: Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line. Hepatology 9(2):210-214, 1989

    Google Scholar 

  48. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G: Autoimmune hepatitis in childwood: a 20 year experience. Hepatology 25:541-547, 1997

    Google Scholar 

  49. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E: Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation on 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis Hepatology 23:1369-1376, 1996

    Google Scholar 

  50. El-Shabrawi M, Wilkinson ML, Portmann B, Mieli Vergani G, Chong SK, Williams R, Mowat AP: Primary sclerosing cholangitis in childwood. Gastroenterology 92:1226-1235, 1987

    Google Scholar 

  51. Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St. Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L, Roberts EA: Primary sclerosing cholangitis in 32 children: clinical laboratory and radiografic features with survival analysis. Hepatology 22:1415-1422, 1995

    Google Scholar 

  52. McNair AN,Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in 5 cases. Am J Gastroenterol 93:777-784, 1998

    Google Scholar 

  53. Kaya M, Angulo P, Lindor KD: Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 33:537-542, 2000

    Google Scholar 

  54. Lawrence SP, Sherman KE, Lawson JM, Goodman ZD: A 39 year-old man with chronic hepatitis. Semin Liv Dis 14:97-105, 1994

    Google Scholar 

  55. Wurbs D, Klein R, Terracciano LM, Berg PA, Bianchi L: A 28 year old woman with a combined hepatitc-cholestatic syndrome. Hepatology 22:1598-1605, 1995

    Google Scholar 

  56. Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH: Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 24:699-705, 1996

    Google Scholar 

  57. Luketic VA, Gomez DA, Sanyal AJ, Shiffman ML: An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci 42:2009-2016, 1997

    Google Scholar 

  58. Seeff LB: Strategies for assessing the long-term consequences of Hepatitis C virus infection. Min Gastroenterol Dietol 46:207-216, 2000

    Google Scholar 

  59. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, Muratori L, Lenzi M, Bianchi G, Zauli D, Bianchi FB: Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26:561-566, 1997

    Google Scholar 

  60. Durazzo M, Philipp T, Van Pelt FN, Lutting B, Borghesio E, Michel G, Schmidt E, Loges S, Rizzetto M, Manns MP: Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection. Gastroenterology 108 (2):455-462, 1995

    Google Scholar 

  61. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM, Opolon P, Homberg JC: Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16:630-636, 1992

    Google Scholar 

  62. Vergani D: NOSA in HCV infection: markers or makers of disease? Gut 45:328-329, 1999

    Google Scholar 

  63. Bortolotti F, Vajro P, Balli F, Crivellario C, Barbera C, Cataleta M, Muratori L, Pontisso P, Nebbia G, Zancan L, Bertolini A, Alberti A, Bianchi F: Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 25:614-620, 1996

    Google Scholar 

  64. Manns MP, Obermayer-Straub P: Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 26:1054-1066, 1997

    Google Scholar 

  65. Czaja AJ, Carpenter HA: Histological findings in chronic hepatitis C with autoimmune features. Hepatology 26:459-466, 1997

    Google Scholar 

  66. Czaja AJ: Overlap of chronic viral hepatitis and autoimmune hepatitis. In Viral Hepatitis: Diagnosis, Treatment, Prevention. RA Wilson (ed). New York, Marcel Dekker, 1997, pp 371-399

    Google Scholar 

  67. Hano H, Takasaki S, Nakayama J: Autoimmune forms of chronic hepatitis associated with hepatitis C virus (HCV) infection with and without HCV-RNA: histological differences from pure autoimmune hepatitis and chronic hepatitis C. Pathol Int 50:106-112, 2000

    Google Scholar 

  68. Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM1 antibodies recognize a short linear sequenze in P450IID6, a cytochrome P450 monooxygenase. J Clin Invest 88:1370-1378, 1991

    Google Scholar 

  69. Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde KH, Decker R, Manns MP: Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339:267-269, 1992

    Google Scholar 

  70. Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 90(8):1206-1211, 1995

    Google Scholar 

  71. Todros L, Saracco G, Durazzo M, Abate ML, Touscoz G, Scaglione L, Verme G, Rizzetto M: Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver kidney microsomes. Hepatology 22(5):1374-1378, 1995

    Google Scholar 

  72. Strettel MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R: Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112:2028-2035, 1997

    Google Scholar 

  73. Czaja AJ: Drug therapy in the management of autoimmune hepatitis 1. Drugs 57:49-68, 1999

    Google Scholar 

  74. Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB: Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 21:199-203, 1994

    Google Scholar 

Download references

Authors
  1. Marilena Durazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Premoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sharmila Fagoonee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rinaldo Pellicano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durazzo, M., Premoli, A., Fagoonee, S. et al. REVIEW: Overlap Syndromes of Autoimmune Hepatitis: What Is Known So Far. Dig Dis Sci 48, 423–430 (2003). https://doi.org/10.1023/A:1022597210629

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022597210629

Search

Navigation